Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2024-01-05 00:00:00 ET · period of report 2024-01-04 · accession 0001415889-24-000775 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-05 | 2024-01-04 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $227.97 | -6,000 | 40.9K | -13% | -$1.37M |
| D | 2024-01-05 | 2024-01-04 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.6K | +16% | +$706.6K |
| D | 2024-01-05 | 2024-01-04 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -6,000 | 84.0K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-04 | S | D | 300 | $228.83 | 36,599 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $228.71 to $229.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2024-01-04 | S | D | 3,990 | $228.17 | 36,899 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $227.67 to $228.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2024-01-04 | S | D | 1,710 | $227.34 | 40,889 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $226.66 to $227.645. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2024-01-04 | M | A | 6,000 | $117.76 | 42,599 | D | — | — | |
| 5 | Derivative | Stock Options | 2024-01-04 | M | D | 6,000 | $0.00 | 84,000 | D | $117.76 · 2021-03-15 to 2027-03-15 | 6,000 Common Stock |